SPAC3F10.08c Antibody

Shipped with Ice Packs
In Stock

Description

Introduction

Antibodies, or immunoglobulins, are Y-shaped proteins critical to the immune system for recognizing and neutralizing pathogens. While the search results provided do not specifically mention the "SPAC3F10.08c Antibody," this article synthesizes general antibody structure, function, and research methodologies from the available sources to frame how such a compound might be analyzed.

2.1. General Structure

Antibodies consist of two heavy chains and two light chains, forming a Y-shape with two Fab fragments (antigen-binding) and one Fc region (effector interactions) . The Fab fragments contain variable domains (VH/VL) that bind epitopes, while the Fc region interacts with immune cells and the complement system . Proteolytic enzymes like papain cleave antibodies into Fab and Fc fragments, aiding functional studies .

2.2. Classes of Antibodies

ClassStructureFunctionKey Features
IgGMonomericNeutralization, opsonizationMost abundant in blood; crosses placenta
IgAMonomeric/dimericMucosal immunityResists proteolysis; secreted into mucosa
IgMPentamericComplement activationLarge size; first-line defense
IgEMonomericAllergy/parasite responseBinds mast cells/basophils
IgDMonomericB-cell receptorShort half-life (3 days)

3.1. SARS-CoV-2 Neutralizing Antibodies

Recent studies highlight antibody evasion by Omicron subvariants. For example, BA.4/5 exhibits 4.2-fold resistance to sera from vaccinated individuals compared to BA.2, driven by mutations like F486V and L452M/R/Q . Neutralizing titers correlate with protection, with thresholds of 100–1,000 IU50/ml linked to efficacy .

3.2. IgA in Mucosal Therapeutics

IgA antibodies show promise in enteric applications due to their stability in intestinal fluid. Studies demonstrate SIgA1 retains functional activity against E. coli toxins despite degradation, suggesting potential for targeted therapies .

4.1. Limitations in Current Data

  1. Epitope Mapping: Identifying target antigens and binding affinity .

  2. Neutralization Assays: Measuring ability to block pathogen entry .

  3. Stability Testing: Assessing degradation in physiological conditions (e.g., simulated intestinal fluid) .

  4. Fc Region Studies: Evaluating interactions with effector cells/complement .

4.2. Hypothetical Application

If SPAC3F10.08c were a monoclonal antibody (mAb), its development might involve:

  • Cloning: Isolating variable regions (VH/VL) and engineering into IgG or IgA frameworks .

  • Therapeutic Targets: Viral antigens (e.g., SARS-CoV-2 spike) , bacterial toxins , or autoimmune antigens .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPAC3F10.08c antibody; Uncharacterized protein C3F10.08c antibody
Target Names
SPAC3F10.08c
Uniprot No.

Q&A

What is SPAC3F10.08c and why would researchers develop antibodies against it?

SPAC3F10.08c is a gene locus in S. pombe that encodes a protein involved in cellular processes. Researchers develop antibodies against this protein to study its expression patterns, localization, interactions, and functions. The antibody allows visualization, quantification, and isolation of the target protein from complex biological samples. Given that S. pombe is a model organism with conserved cellular mechanisms relevant to higher eukaryotes, including humans, studying SPAC3F10.08c can provide insights into fundamental biological processes.

What validation methods should be employed when testing a new SPAC3F10.08c antibody?

A thorough validation process for SPAC3F10.08c antibodies should include:

  • Western blot analysis using wild-type S. pombe extracts versus SPAC3F10.08c deletion mutants

  • Immunoprecipitation followed by mass spectrometry to confirm target specificity

  • Immunofluorescence comparing wild-type and deletion strains

  • Testing cross-reactivity against recombinant SPAC3F10.08c protein

  • Dot blot analysis with antigenic peptides

For optimal validation, multiple detection methods should be employed simultaneously, as demonstrated in approaches used for other research antibodies .

Which applications are SPAC3F10.08c antibodies most commonly used for?

SPAC3F10.08c antibodies are typically employed in:

ApplicationCommon Dilution RangeKey Optimization Parameters
Western Blotting1:500-1:5000Reducing vs. non-reducing conditions; blocking agent selection
Immunofluorescence1:50-1:500Fixation method; permeabilization conditions
Immunoprecipitation1:50-1:200Buffer composition; incubation time
ChIP1:50-1:100Crosslinking time; sonication parameters
Flow Cytometry1:50-1:200Cell preparation; antibody concentration

The exact protocols would need to be optimized similar to those established for other research antibodies such as TSPAN8 .

How should I optimize fixation and permeabilization for immunofluorescence with SPAC3F10.08c antibodies?

For optimal immunofluorescence results with SPAC3F10.08c antibodies:

  • Fixation options comparison:

    • 4% paraformaldehyde (10-15 minutes) preserves structural integrity but may reduce epitope accessibility

    • Methanol fixation (-20°C, 6 minutes) often provides better epitope exposure but can disrupt membrane structures

    • Hybrid protocols using both may be optimal for membrane-associated proteins

  • Permeabilization optimization:

    • Test 0.1% Triton X-100 (5-10 minutes)

    • Compare with 0.5% Saponin (gentler for membrane proteins)

    • For challenging epitopes, try 0.5% SDS brief exposure (30 seconds)

Each fixation method affects epitope accessibility differently, requiring systematic comparison similar to protocols established for other antibodies in ICC applications .

What are the optimal sample preparation techniques for detecting SPAC3F10.08c by Western blot?

For successful Western blot detection of SPAC3F10.08c:

  • Cell lysis optimization:

    • Compare RIPA buffer with NP-40 based buffers

    • Include protease inhibitor cocktail specifically optimized for yeast proteins

    • Test mechanical disruption (glass beads) versus chemical lysis

  • Sample treatment:

    • Compare reducing (with DTT or β-mercaptoethanol) versus non-reducing conditions

    • Test denaturation at different temperatures (37°C, 65°C, and 95°C for 5-10 minutes)

    • For membrane proteins, avoid boiling as it may cause aggregation

  • Loading controls:

    • Include both housekeeping protein controls and total protein staining

    • Test transfer efficiency with prestained markers

This systematic approach is similar to Western blot protocols established for other cellular proteins like TSPAN8, which demonstrated specific bands at expected molecular weights under non-reducing conditions .

How can I troubleshoot non-specific binding when using SPAC3F10.08c antibodies?

When encountering non-specific binding:

  • Blocking optimization:

    • Test different blocking agents (5% BSA, 5% non-fat milk, commercial blockers)

    • Extend blocking time (1-3 hours at room temperature or overnight at 4°C)

    • Consider adding 0.1-0.3% Tween-20 to washing buffers

  • Antibody dilution optimization:

    • Test serial dilutions to identify optimal concentration

    • Prepare antibody in fresh blocking solution

    • Consider overnight incubation at 4°C rather than shorter incubations

  • Advanced troubleshooting:

    • Pre-adsorb antibody with yeast lysate from SPAC3F10.08c deletion strain

    • Test alternative secondary antibodies with minimal cross-reactivity

    • Apply gradient washing with increasing stringency

These approaches mirror troubleshooting strategies employed with other research antibodies that showed initial cross-reactivity issues .

How can I optimize SPAC3F10.08c antibodies for chromatin immunoprecipitation (ChIP) experiments?

Optimizing ChIP with SPAC3F10.08c antibodies requires:

  • Crosslinking optimization:

    • Test formaldehyde concentrations (0.5-3%)

    • Optimize crosslinking time (5-20 minutes)

    • Consider dual crosslinkers for protein-protein interactions (DSG followed by formaldehyde)

  • Sonication parameters:

    • Optimize sonication cycles to achieve 200-500bp fragments

    • Verify fragmentation by agarose gel electrophoresis

    • Consider enzymatic shearing alternatives

  • Immunoprecipitation conditions:

    • Test different antibody concentrations

    • Compare protein A/G beads with specific anti-species beads

    • Optimize wash stringency to reduce background

What considerations should I take into account when using SPAC3F10.08c antibodies for co-immunoprecipitation studies?

For co-immunoprecipitation with SPAC3F10.08c antibodies:

  • Lysis buffer optimization:

    • Use gentle non-ionic detergents (0.5% NP-40 or 1% Digitonin)

    • Include stabilizers like glycerol (10%) to preserve protein-protein interactions

    • Test various salt concentrations (100-150mM NaCl as starting point)

  • Pre-clearing strategies:

    • Pre-clear lysates with beads alone to reduce non-specific binding

    • Consider pre-incubation with non-immune IgG

  • Interaction verification:

    • Perform reciprocal IPs when possible

    • Include appropriate controls (IgG, deletion mutants)

    • Consider mild crosslinking to stabilize transient interactions

  • Elution conditions:

    • Compare different elution methods (competitive with peptide, pH change, SDS)

    • Optimize to maintain interacting protein activity

This approach builds on techniques used in antibody characterization studies focusing on protein complex identification .

How can SPAC3F10.08c antibodies be used to study protein dynamics during the cell cycle?

To study SPAC3F10.08c protein dynamics during the cell cycle:

  • Synchronization methods comparison:

    • Nitrogen starvation and release

    • Hydroxyurea block and release

    • cdc25-22 temperature-sensitive mutant synchronization

  • Time-course experimental design:

    • Collect samples at regular intervals (every 20 minutes for 3-4 hours)

    • Process samples simultaneously for immunoblotting

    • Include cell cycle markers (Cdc13, Cdc2-P) as controls

  • Quantitative analysis:

    • Normalize SPAC3F10.08c protein levels to loading controls

    • Plot protein abundance against cell cycle progression markers

    • Perform at least three biological replicates for statistical significance

  • Validation by fluorescence microscopy:

    • Use fixed time points to correlate protein levels with localization

    • Co-stain with DNA and septum markers to determine cell cycle stage

This methodological approach employs techniques similar to those used in studies of protein expression dynamics in cell line models .

How should I interpret contradictory results between different detection methods using SPAC3F10.08c antibodies?

When faced with contradictory results:

  • Systematic evaluation framework:

    • Compare epitope accessibility across different techniques

    • Assess whether native protein conformation affects antibody binding

    • Consider post-translational modifications that might affect epitope recognition

  • Cross-validation approaches:

    • Use alternative antibodies targeting different epitopes if available

    • Employ epitope-tagged versions of SPAC3F10.08c as controls

    • Integrate orthogonal techniques (MS-based proteomics)

  • Technical considerations:

    • Evaluate buffer compatibility across different applications

    • Assess whether sample preparation affects protein state

    • Consider whether detergents or fixatives modify epitope accessibility

Such methodical analysis approaches are essential when working with novel antibodies, as demonstrated in comprehensive antibody validation studies .

What controls are essential when publishing research using SPAC3F10.08c antibodies?

Essential controls for publication-quality research include:

Control TypePurposeImplementation
Genetic Negative ControlValidate antibody specificityUse SPAC3F10.08c deletion strain
Loading ControlEnsure equal loadingUse housekeeping protein antibodies and total protein staining
Secondary Antibody ControlDetect non-specific bindingOmit primary antibody
Peptide CompetitionConfirm epitope specificityPre-incubate antibody with immunizing peptide
Positive ControlVerify technique functionalityUse overexpression strain or recombinant protein
Isotype ControlControl for non-specific bindingUse matched isotype non-immune IgG

When publishing, include detailed methods sections describing antibody validation and all controls used, following practices established in high-quality antibody research publications .

How can I quantitatively assess antibody cross-reactivity with other S. pombe proteins?

To assess cross-reactivity quantitatively:

  • Comprehensive cross-reactivity testing:

    • Perform Western blots on wild-type versus SPAC3F10.08c deletion strains

    • Compare signal intensity ratios between specific and non-specific bands

    • Calculate signal-to-noise ratios across different antibody concentrations

  • Advanced analytical methods:

    • Use immunoprecipitation followed by mass spectrometry to identify all pulled-down proteins

    • Calculate enrichment factors for SPAC3F10.08c versus other proteins

    • Establish threshold criteria for acceptable specificity

  • Epitope mapping and sequence analysis:

    • Identify the specific epitope recognized by the antibody

    • Perform BLAST analysis against the S. pombe proteome to identify proteins with similar sequences

    • Test cross-reactivity against predicted similar proteins

This quantitative approach to antibody validation is consistent with methods used in characterizing high-specificity antibodies for research applications .

What buffer systems optimize SPAC3F10.08c antibody performance in different applications?

Buffer optimization strategies include:

  • Western blotting buffers:

    • TBST (20mM Tris, 150mM NaCl, 0.1% Tween-20, pH 7.5) for standard applications

    • PBST for phosphorylated epitopes

    • Consider adding 5mM EDTA for metal-dependent epitopes

  • Immunoprecipitation buffers:

    • Low stringency: 50mM Tris-HCl pH 7.5, 150mM NaCl, 0.5% NP-40, 1mM EDTA

    • Medium stringency: Add 0.1% SDS and increase NaCl to 250mM

    • High stringency: Add 0.5% sodium deoxycholate and increase NaCl to 500mM

  • Immunofluorescence buffers:

    • PBS with 0.1% Triton X-100 for standard permeabilization

    • PBS with 0.1% Saponin for membrane proteins

    • Add 1% BSA to all buffers to reduce background

Buffer composition significantly impacts antibody performance, as demonstrated in protocols for detection of membrane proteins like TSPAN8 .

How should SPAC3F10.08c antibodies be stored for maximum longevity and performance?

For optimal storage and maintenance:

  • Storage conditions comparison:

    • Short-term (≤1 month): 4°C with 0.02% sodium azide

    • Medium-term (1-6 months): -20°C in 50% glycerol

    • Long-term (>6 months): -80°C in small aliquots

  • Stability-enhancing additives:

    • Add carrier proteins (BSA at 1-5 mg/ml)

    • Include stabilizers like glycerol (30-50%)

    • Consider commercial antibody stabilizers

  • Performance monitoring protocol:

    • Test activity every 3-6 months

    • Compare with initial validation results

    • Document any sensitivity changes

  • Freeze-thaw minimization strategies:

    • Prepare multiple small-volume aliquots

    • Use dedicated working stocks

    • Avoid more than 5 freeze-thaw cycles

These storage recommendations align with best practices for maintaining antibody activity in research settings, similar to those recommended for other research antibodies .

What are the recommended approaches for multiplexing SPAC3F10.08c antibodies with other markers in imaging experiments?

For successful multiplexing in imaging:

  • Antibody compatibility assessment:

    • Test primary antibodies from different host species

    • Verify secondary antibody cross-reactivity

    • Validate spectral separation of fluorophores

  • Sequential staining protocols:

    • Use Fab fragments to block remaining primary antibody binding sites between rounds

    • Consider tyramide signal amplification for weak signals

    • Test elution methods between sequential staining rounds

  • Advanced multiplexing strategies:

    • Employ spectral unmixing for overlapping fluorophores

    • Consider cyclic immunofluorescence for >4 markers

    • Validate with single-stained controls and no-primary controls

These approaches build on established protocols for multicolor immunofluorescence, such as those demonstrated in cellular localization studies of membrane proteins .

How can I distinguish between true SPAC3F10.08c signal and artifacts in immunofluorescence experiments?

To distinguish genuine signal from artifacts:

  • Systematic controls implementation:

    • Compare wild-type with SPAC3F10.08c deletion strains

    • Test pre-immune serum or isotype-matched control antibodies

    • Include secondary-only controls

    • Perform peptide competition assays

  • Signal validation approaches:

    • Cross-validate with GFP-tagged SPAC3F10.08c

    • Compare fixed versus live cell imaging when possible

    • Test multiple fixation methods

    • Analyze co-localization with known marker proteins

  • Artifact identification guide:

Artifact TypeCharacteristicsMitigation Strategy
AutofluorescencePresent in all channels, resistant to photobleachingInclude unstained controls, use spectral unmixing
Non-specific bindingOften present at cell periphery, variable between cellsOptimize blocking, include deletion strain controls
Fixation artifactsPattern changes with different fixation methodsCompare multiple fixation approaches
Bleed-throughSignal correlates between channelsUse sequential scanning, proper filter sets

These validation approaches mirror those used in high-quality immunofluorescence studies of cellular proteins .

What are the best approaches for quantifying SPAC3F10.08c protein levels using Western blotting?

For accurate protein quantification:

  • Sample preparation standardization:

    • Use consistent cell numbers/tissue amounts

    • Standardize lysis conditions

    • Include protease/phosphatase inhibitors

  • Loading and normalization strategies:

    • Use total protein normalization (Ponceau S, REVERT stain)

    • Compare with multiple housekeeping proteins

    • Include standard curves with recombinant protein

  • Image acquisition optimization:

    • Capture images within linear dynamic range

    • Use exposure times that avoid saturation

    • Include technical replicates on each blot

  • Quantification tools comparison:

    • Test different analysis software (ImageJ, Image Lab, etc.)

    • Use consistent background subtraction methods

    • Apply statistical analysis across biological replicates

This quantitative approach is consistent with methodologies used in protein expression analysis studies that require precise quantification .

How can I use SPAC3F10.08c antibodies to study protein-protein interactions and molecular complexes?

For studying protein interactions:

  • Co-immunoprecipitation optimization:

    • Test different lysis buffers to preserve interactions

    • Optimize antibody-to-lysate ratios

    • Consider crosslinking before lysis for transient interactions

    • Include appropriate controls (reverse IP, IgG controls)

  • Proximity ligation assay implementation:

    • Combine SPAC3F10.08c antibody with antibodies against suspected interaction partners

    • Optimize antibody concentrations and incubation times

    • Include positive controls (known interactions) and negative controls

  • Mass spectrometry integration:

    • Use quantitative approaches (SILAC, TMT) to distinguish specific from non-specific interactors

    • Compare immunoprecipitates from wild-type and deletion strains

    • Apply stringent statistical criteria for identifying bona fide interactors

These methodological approaches mirror those used in comprehensive protein interaction studies that identified functional protein complexes, similar to techniques used in antibody characterization research .

How can SPAC3F10.08c antibodies be adapted for super-resolution microscopy techniques?

For super-resolution microscopy applications:

  • Direct immunofluorescence approach:

    • Directly conjugate SPAC3F10.08c antibodies with photoswitchable fluorophores

    • Optimize degree of labeling (typically 1-3 fluorophores per antibody)

    • Validate retention of binding specificity post-conjugation

  • STORM/PALM optimization:

    • Test different buffer systems (MEA, GLOX)

    • Optimize labeling density for reconstruction

    • Use fiducial markers for drift correction

  • Expansion microscopy adaptation:

    • Test antibody compatibility with anchoring and gel formation

    • Validate epitope retention after expansion

    • Optimize post-expansion staining if pre-expansion signal is lost

Super-resolution microscopy requires additional validation steps beyond standard immunofluorescence, focusing on spatial precision and molecular localization accuracy .

What are the considerations for using SPAC3F10.08c antibodies in FACS-based assays?

For flow cytometry applications:

  • Cell preparation optimization:

    • Test fixation methods (paraformaldehyde, methanol)

    • Optimize permeabilization conditions for intracellular staining

    • Develop single-cell suspension protocols for yeast cells

  • Antibody titration and validation:

    • Generate titration curves to determine optimal concentration

    • Calculate signal-to-noise ratios at different concentrations

    • Validate with appropriate controls (deletion strains)

  • Multiparameter assay design:

    • Include cell cycle markers (DNA content)

    • Test compatibility with live/dead discrimination dyes

    • Develop compensation protocols for multiple fluorophores

Flow cytometry provides quantitative single-cell data and requires specific optimization for yeast cells, with approaches similar to those developed for mammalian cell surface proteins .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.